At close: December 20 at 4:00:00 PM EST
After hours: December 20 at 7:59:18 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 1 | 4 | 4 |
| Avg. Estimate | -0.39 | -0.41 | -1.42 | -0.66 |
| Low Estimate | -0.44 | -0.41 | -1.5 | -1.28 |
| High Estimate | -0.29 | -0.41 | -1.24 | 0.16 |
| Year Ago EPS | -0.33 | -0.31 | -1.83 | -1.42 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 1 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | 14.74M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 38.7M |
| Year Ago Sales | 81k | -- | 81k | -- |
| Sales Growth (year/est) | -100.00% | 0.00% | -100.00% | 0.00% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.54 | -0.52 | -0.4 | -0.37 |
| EPS Actual | -0.33 | -0.31 | -0.38 | -0.37 |
| Difference | 0.21 | 0.21 | 0.02 | -0 |
| Surprise % | 38.51% | 40.38% | 5.00% | -0.91% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.39 | -0.41 | -1.42 | -0.66 |
| 7 Days Ago | -0.43 | -0.34 | -1.5 | -0.85 |
| 30 Days Ago | -0.3 | -0.34 | -1.37 | -0.71 |
| 60 Days Ago | -0.34 | -0.34 | -1.42 | -0.76 |
| 90 Days Ago | -0.34 | -0.34 | -1.42 | -0.76 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | 1 | -- | 1 |
| Down Last 30 Days | 3 | 1 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ATNM | -18.18% | -32.26% | 22.13% | 53.86% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Reiterates | Stephens & Co.: Overweight to Overweight | 11/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/6/2024 |
| Maintains | Maxim Group: Buy to Buy | 8/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/26/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/17/2024 |
Related Tickers
ACET Adicet Bio, Inc.
0.9100
+5.78%
SLS SELLAS Life Sciences Group, Inc.
0.8880
-1.11%
ENTX Entera Bio Ltd.
2.1000
-3.23%
AFMD Affimed N.V.
1.1900
+0.85%
AGEN Agenus Inc.
2.8300
+2.54%
MREO Mereo BioPharma Group plc
3.3500
+1.82%
ALLK Allakos Inc.
1.2000
-6.98%
RVPH Reviva Pharmaceuticals Holdings, Inc.
1.3400
-10.67%
AXSM Axsome Therapeutics, Inc.
90.73
+1.10%
ATYR aTyr Pharma, Inc.
3.3500
+6.35%